Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Vet Pathol ; 48(4): 868-74, 2011 Jul.
Article in English | MEDLINE | ID: mdl-21123858

ABSTRACT

The authors have determined a consensus sequence for exons 1 and 2 of H-ras from captive lemurs and lorises and evaluated samples of nonneoplastic liver and hepatocellular carcinomas (HCC) from affected animals for mutations in these exons. Frozen liver samples were collected from 20 animals representing 9 different species with a sex distribution of 10 males and 10 females. A total of 26 liver samples, including 11 normal livers, 9 HCC, and 6 samples from nonneoplastic regions of liver from animals with HCC, were evaluated. This is the first report of the consensus sequence for exons 1 and 2 of H-ras in prosimians, and the authors have determined that it is identical to that of human H-ras and differs only slightly from the chimpanzee sequence. Point mutations were identified in 6 of the 9 HCC samples examined with codons 7, 22, 32, 56, 61, 84, and 96 affected. Two carcinomas had double mutations, and one tumor had triple mutations. One HCC had a mutation in codon 61, which is identical to a recognized affected codon for an H-ras "hot spot" in rodent neoplasia that has also been reported in human tumors. Although not statistically different, metastasis occurred in 5 of 6 HCC with H-ras mutation and only 1 of 3 HCC without mutations. There were 4 silent mutations that did not contain changes in the encoded amino acids, 2 of which were found in nonneoplastic regions of tumor-bearing liver.


Subject(s)
Carcinoma, Hepatocellular/veterinary , Genes, ras/genetics , Lemur , Liver Neoplasms/veterinary , Lorisidae , Primate Diseases/genetics , Animals , Carcinoma, Hepatocellular/genetics , Carcinoma, Hepatocellular/pathology , Consensus Sequence , Female , Gene Expression Regulation, Neoplastic , Liver Neoplasms/genetics , Liver Neoplasms/pathology , Male , Mutation , Primate Diseases/pathology
2.
J Cell Biochem ; 82(3): 415-21, 2001.
Article in English | MEDLINE | ID: mdl-11500918

ABSTRACT

Normal human somatic cells, unlike cancer cells, stop dividing after a limited number of cell divisions through the process termed cellular senescence or replicative senescence, which functions as a tumor-suppressive mechanism and may be related to organismal aging. By means of the cDNA subtractive hybridization, we identified eight genes upregulated during normal chromosome 3-induced cellular senescence in a human renal cell carcinoma cell line. Among them is the DNCI1 gene encoding an intermediate chain 1 of the cytoplasmic dynein, a microtubule motor that plays a role in chromosome movement and organelle transport. The DNCI1 mRNA was also upregulated during in vitro aging of primary human fibroblasts. In contrast, other components of cytoplasmic dynein showed no significant change in mRNA expression during cellular aging. Cell growth arrest by serum starvation, contact inhibition, or gamma-irradiation did not induce the DNCI1 mRNA, suggesting its specific role in cellular senescence. The DNCI1 gene is on the long arm of chromosome 7 where tumor suppressor genes and a senescence-inducing gene for a group of immortal cell lines (complementation group D) are mapped. This is the first report that links a component of molecular motor complex to cellular senescence, providing a new insight into molecular mechanisms of cellular senescence.


Subject(s)
Cellular Senescence/genetics , Dyneins/genetics , Up-Regulation , Cell Division , Chromosomes, Human, Pair 3/genetics , Dyneins/chemistry , Fibroblasts , Humans , Kidney Neoplasms/genetics , RNA, Messenger/genetics , RNA, Messenger/metabolism , Sequence Analysis, DNA , Tumor Cells, Cultured
3.
Muscle Nerve ; 21(8): 991-8, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9655116

ABSTRACT

Golden retriever muscular dystrophy (GRMD), the canine model of Duchenne muscular dystrophy (DMD), is caused by a splice site mutation in the dystrophin gene. This mutation predicts a premature termination codon in exon 8 and a peptide that is 5% the size of normal dystrophin. Western blot analysis of skeletal muscle from GRMD dogs reveals a slightly truncated 390-kD protein that is approximately 91% the size of normal dystrophin. This 390-kD dystrophin suggests that GRMD dogs, like some DMD patients, employ a mechanism to overcome their predicted frameshift. Reverse-transcriptase polymerase chain reaction on GRMD muscle has revealed two in-frame dystrophin transcripts which lack either exons 3-9 or exons 5-12. Both transcripts could be translated into a dystrophin protein of approximately 390 kD. An understanding of how truncated dystrophin is produced in GRMD may allow this mechanism to be manipulated toward a potential therapy for DMD.


Subject(s)
Alternative Splicing/genetics , Dystrophin/genetics , Muscular Dystrophies/genetics , Muscular Dystrophy, Animal/genetics , Animals , Antibodies, Monoclonal , Base Sequence , Blotting, Western , DNA Mutational Analysis , Disease Models, Animal , Dogs , Dystrophin/analysis , Dystrophin/immunology , Exons/genetics , Molecular Sequence Data , Muscle, Skeletal/chemistry , Muscle, Skeletal/physiopathology , Phenotype , Polymerase Chain Reaction , Transcription, Genetic/physiology
4.
Nature ; 391(6668): 707-10, 1998 Feb 12.
Article in English | MEDLINE | ID: mdl-9490416

ABSTRACT

Reactive oxygen species have damaging effects on cellular components and so trigger defensive responses by the cell and even programmed cell death, although the mechanisms by which mammalian cells transmit signals in response to oxidative damage are unknown. We report here that the protein p85, a regulator of the signalling protein phosphatidyl-3-OH kinase (PI(3)K), participates in the cell death process that is induced in response to oxidative stress and that this role of p85 in apoptosis does not involve PI(3)K. We show that disruption of p85 by homologous recombination impairs the cellular apoptotic response to oxidative stress. Because the protein p53 is required for cell death induced by oxidative damage, we examined the relation between p85 and p53. Using a chimaeric p53 fusion protein with the oestrogen receptor (p53ER) to supply p53 (p53 is induced upon binding of p53ER to oestradiol) in a p53-deficient cell line, we found that p85 is upregulated by p53 and that its involvement in p53-mediated apoptosis is independent of PI(3)K. We propose that p85 acts as a signal transducer in the cellular response to oxidative stress, mediating cell death regulated by p53.


Subject(s)
Apoptosis , Oxidative Stress , Phosphatidylinositol 3-Kinases/metabolism , Tumor Suppressor Protein p53/physiology , Androstadienes/pharmacology , Animals , Antisense Elements (Genetics) , Cell Line , Enzyme Inhibitors/pharmacology , Fibroblasts/cytology , Fibroblasts/drug effects , Fibroblasts/enzymology , Humans , Hydrogen Peroxide/pharmacology , Mice , Phosphatidylinositol 3-Kinases/genetics , Phosphoinositide-3 Kinase Inhibitors , Recombinant Fusion Proteins/metabolism , Signal Transduction , Tumor Cells, Cultured , Tumor Suppressor Protein p53/genetics , Wortmannin
SELECTION OF CITATIONS
SEARCH DETAIL
...